admera_health_final_logo_transparent_final.jpg
Admera Health Expands Liquid Biopsy Offering to Include Detection of Copy Number Variation and Microsatellite Instability
23 oct. 2018 09h13 HE | Admera Health, LLC
SOUTH PLAINFIELD, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- At CAP18, in Chicago, IL, Admera Health (www.admerahealth.com), unveiled an expansion to its next generation sequencing (NGS) based...
admera_health_final_logo_transparent_final.jpg
Admera Health Expands Asian Footprint with Three Strategic Partnerships
12 sept. 2017 11h05 HE | Admera Health, LLC
SOUTH PLAINFIELD, N.J., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Today, Admera Health announced agreements expanding Admera’s portfolio of molecular diagnostics to Asia, including but not limited to...
admera_health_final_logo_transparent_final.jpg
Admera Health Expands Oncology Test Portfolio with Launch of OncoGxSelect™ at the AMP 2016 Annual Meeting
09 nov. 2016 09h13 HE | Admera Health, LLC
SOUTH PLAINFIELD, N.J. and CHARLOTTE, N.C., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Molecular diagnostics company, Admera Health announced the official launch of OncoGxSelect™ while exhibiting at the...